Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy

Leuk Lymphoma. 2016;57(4):969-72. doi: 10.3109/10428194.2015.1085533. Epub 2015 Oct 9.

Authors

Roberta Fedele¹, Maria Cuzzola¹, Giuseppe Irrera¹, Antonella Pontari¹, Domenico Giuseppe D'Ascola², Esther Natalie Oliva³, Massimo Martino¹

Affiliations

¹ a Department of Oncology and Hematology , Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera BMM , Reggio Calabria , Italy .
² b Microcythemia Center, Azienda Ospedaliera BMM , Reggio Calabria , Italy , and.
³ c Department of Oncology and Hematology , Hematology Division, Azienda Ospedaliera BMM , Reggio Calabria , Italy.

PMID: 26308385
DOI: 10.3109/10428194.2015.1085533

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Chelation Therapy*
Graft vs Host Disease / drug therapy
Graft vs Host Disease / etiology
Hematopoietic Stem Cell Transplantation / adverse effects*
Humans
Iron Chelating Agents / therapeutic use*
Iron Overload / drug therapy*
Iron Overload / etiology
Leukemia, Myeloid, Acute / complications
Leukemia, Myeloid, Acute / diagnosis
Leukemia, Myeloid, Acute / therapy
Middle Aged
Polycythemia / diagnosis
Polycythemia / etiology*
Transfusion Reaction

Substances

Iron Chelating Agents